The stratified analysis also revealed that high PLCE1 expression increased the risk of recurrence and death in patients who were male and had early-stage BCLC, a single tumor, cirrhosis, and AFP level > 300 ng/ml. This evidence concerns the gene PLCE1 and neoplasm.